OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sempervirine Inhibits Proliferation and Promotes Apoptosis by Regulating Wnt/β-Catenin Pathway in Human Hepatocellular Carcinoma
Rongcai Yue, Haiping Liu, Yaxin Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11

Showing 11 citing articles:

Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo
Danni Chen, Yan Tan, Tingting Chen, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1

Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 17

Recent progress in chemistry and bioactivity of monoterpenoid indole alkaloids from the genus gelsemium : a comprehensive review
Lin Wang, Siyu Chen, Xun Gao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 16

Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
Alexander Marr, Madeline Halpin, Dominique Corbin, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer
Xintong Zhou, Xiaomin Wang, Qi Sun, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113096-113096
Open Access | Times Cited: 21

Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine
Anita K. Bakrania, Jeffrey C. To, Gang Zheng, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 948-963
Open Access | Times Cited: 8

Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: A review
Priyadarshini Mohapatra, Natarajan Chandrasekaran
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113713-113713
Open Access | Times Cited: 9

Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma
Peng Liu, Bing Han, Yanxia Zhang, et al.
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 3

Exploring the Mechanism of Sempervirine Inhibiting Glioblastoma Invasion Based on Network Pharmacology and Bioinformatics
Bingqiang Zhang, Wenyi Wang, Song Yu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1318-1318
Open Access

The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects
Shihui Ma, Guorui Meng, Ying Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117508-117508
Open Access

Page 1

Scroll to top